← Back to headlines
Bank of America Lowers McKesson Price Target Amid GLP-1 Pricing Pressure
Bank of America has lowered its price target for McKesson (MCK), citing concerns over pricing pressure related to GLP-1 drugs. This adjustment reflects potential challenges for the healthcare company in the current market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
